COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®25/06/2018
-   
  Sanofi: Disclosure of trading in own shares25/06/2018
-   
  Sanofi : Déclaration des transactions sur actions propres25/06/2018
-   
  Ossur Hf : Transactions in relation to share buyback program25/06/2018
-   
  EUROBIO SCIENTIFIC VA COMMERCIALISER LA GAMME TRIAGE® DE QUIDEL25/06/2018
-   
  Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes25/06/2018
-   
  Gefion Group Investments A/S provisionally extends offer period25/06/2018
-   
  Scapa Healthcare Closed Fiscal Year with Significant Enhancements of Capabilities and Technologies25/06/2018
-   
  Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region25/06/2018
-   
  “Grindeks” completes acquisition of “HBM Pharma” s.r.o.25/06/2018
-   
  ViroGates A/S: Registration of capital increase and admission to trading25/06/2018
-   
  MannKind Set to Join Russell 3000® Index25/06/2018
-   
  La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA™ (angiotensin II)25/06/2018
-   
  BlissCo Executing Its Plan, Oils and Extracts Up Next -- CFN Media25/06/2018
-   
  Microbot Medical Strengthens Global IP with Issued Patent in India Covering the Company’s ViRob™ Technology Platform25/06/2018
-   
  High Hampton Expands Strategic Network in California -- CFN Media25/06/2018
-   
  ORYZON announces First Patients in the UK in ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-200125/06/2018
-   
  Marrone Bio Innovations Joins the Russell 2000 Index25/06/2018
-   
  FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares25/06/2018
Pages